Record Quarterly Revenue
Insulet surpassed $700 million in quarterly revenue for the first time with 28% year-over-year growth at constant currency rates.
Strong Growth in International Markets
International revenue grew 40% year-over-year on a constant currency basis, driven by the continued rollout of Omnipod 5.
U.S. Type 2 Market Expansion
New customer starts in the U.S. Type 2 market more than doubled year-over-year and grew sequentially by 26%.
Improved Operating Margins
Operating margins expanded 90 basis points year-over-year to 17.1%, driven by operating leverage and strategic investments.
Successful Debt Management
Insulet eliminated all convertible debt from its capital structure, improving financial flexibility.